Development of amphiphilic γ-PGA-nanoparticle based tumor vaccine: Potential of the nanoparticulate cytosolic protein delivery carrier

Biochemical and Biophysical Research Communications

Volumn 366, Issue 2, 2008, Pages 408-413

  Yoshikawa, Tomoaki ^a,b   Okada, Naoki ^a,b   Oda, Atsushi ^a,b   Matsuo, Kazuhiko ^a,b   Matsuo, Keisuke ^a,b   Mukai, Yohei ^a   Yoshioka, Yasuo ^a   Akagi, Takami ^a,b   Akashi, Mitsuru ^a,b   Nakagawa, Shinsaku ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Antigen presentation processing; Antigen presenting cells; Nanoparticle; Tumor vaccine

Indexed keywords

DRUG CARRIER; NANOPARTICLE; POLY GAMMA GLUTAMIC ACID; TUMOR VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOSOME; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CANCER VACCINES; CELL LINE; DENDRITIC CELLS; DRUG CARRIERS; MICE; NANOPARTICLES; PARTICLE SIZE; POLYGLUTAMIC ACID; PROTEINS;

EID: 37449022610     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.153     Document Type: Article

References (15)

1. Yang S.R., Jeong J.H., Park K., and Kim J.-D. Self-aggregates of hydrophobically modified poly(2-hydroxyethyl aspartamide) in aqueous solution. Colloid Polym. Sci. 281 (2003) 852-861
2. Akagi T., Higashi M., Kaneko T., Kida T., and Akashi M. In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(gamma-glutamic acid). Macromol. Biosci. 5 (2005) 598-602
3. Akagi T., Kaneko T., Kida T., and Akashi M. Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier. J. Control. Release 108 (2005) 226-236
4. + T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120. J. Virol. (2007)
5. Harding C.V., and Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153 (1994) 4925-4933
6. Li Y., Ke Y., Gottlieb P.D., and Kapp J.A. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation. J. Leukoc. Biol. 56 (1994) 616-624
7. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., and Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223 (1999) 77-92
8. Akagi T., Higashi M., Kaneko T., Kida T., and Akashi M. Hydrolytic and enzymatic degradation of nanoparticles based on amphiphilic poly(gamma-glutamic acid)-graft-l-phenylalanine copolymers. Biomacromolecules 7 (2006) 297-303
9. Nakamura N., Sun-Wada G.H., Yamamoto A., Wada Y., and Futai M. Association of mouse sorting nexin 1 with early endosomes. J. Biochem. (Tokyo) 130 (2001) 765-771
10. Nakamura N., Yamamoto A., Wada Y., and Futai M. Syntaxin 7 mediates endocytic trafficking to late endosomes. J. Biol. Chem. 275 (2000) 6523-6529
11. Akagi T., Wang X., Uto T., Baba M., and Akashi M. Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives. Biomaterials 28 (2007) 3427-3436
12. Bramwell V.W., Eyles J.E., and Oya Alpar H. Particulate delivery systems for biodefense subunit vaccines. Adv. Drug Deliv. Rev. 57 (2005) 1247-1265
13. Watts C., and Powis S. Pathways of antigen processing and presentation. Rev. Immunogenet. 1 (1999) 60-74
14. Rock K.L. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17 (1996) 131-137
15. Bevan M.J. Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med. 182 (1995) 639-641